Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Oltean

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Elife|September 4, 2019
Androgen-regulated transcription of <i>ESRP2</i> drives alternative splicing patterns in prostate cancerJennifer Munkley, Ling Li, S R Gokul Krishnan, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 30, 2025
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular diseaseSohni Ria Bhalla, Mussarat Wahid, Jason O Amartey, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySebastian Oltean, Yan Qiu, Joanne K Ferguson, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Elife|September 4, 2019
Androgen-regulated transcription of <i>ESRP2</i> drives alternative splicing patterns in prostate cancerJennifer Munkley, Ling Li, S R Gokul Krishnan, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 30, 2025
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular diseaseSohni Ria Bhalla, Mussarat Wahid, Jason O Amartey, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySebastian Oltean, Yan Qiu, Joanne K Ferguson, et al.
Pageof 6